Marico's Q1 FY26 revenue rose 23%; resurfacing its early-August move to lift Plix-maker Satiya stake to 60%

Marico had reported Q1 FY26 consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2%, and the company had increased its fully diluted stake in Plix-maker Satiya Nutraceuticals to 60% — a move from early August that is resurfacing now.

— FiledThu, 10 Sept, 2026, 17:20 IST·First seen Thu, 10 Sept, 2026, 17:19 IST·Source Financial Express · BrandWagon

What happened

Marico posted Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by a 27.2% rise in India revenue. It raised its stake in Plix-maker Satiya

Key facts

  • Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
  • Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
  • Total income: Rs 3,315 crore, including Rs 56 crore other income
  • Total expenses: Rs 2,659 crore versus Rs 2,075 crore
  • India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
  • International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
  • India profit before tax: Rs 469 crore
  • International profit before tax: Rs 213 crore
  • Marico increased Plix-maker Satiya Nutraceuticals stake to 60% on a fully diluted basis

Why this matters

Increasing its fully diluted stake in Satiya Nutraceuticals to 60% gives Marico majority ownership of the Plix platform and strengthens its inorganic growth position in nutrition and wellness.

What to watch

  • Quarterly India volume growth versus price-led growth.
  • Gross-margin and EBITDA-margin trend relative to the 23.3% revenue growth rate.
  • Plix/Satiya revenue growth, distribution expansion, profitability and integration milestones after the stake increase.
  • Advertising and promotional expense intensity, especially in premium and digital-first categories.
  • Copra, edible-oil, crude-derivative and packaging-cost movements.
  • Management commentary on rural demand, urban consumption and premiumization.
  • Expand Plix/Satiya distribution through Marico's general trade, modern trade and digital channels while preserving its premium wellness positioning.
  • Increase innovation and marketing in foods, nutrition, personal care and other higher-growth premium adjacencies.
  • Prioritize margin management through pricing, pack-size actions, procurement and mix improvement as profit growth trails revenue growth.
  • Evaluate further bolt-on investments or capability partnerships in health, wellness and digital-first consumer brands.